ARTES Biotechnology announce expansion of the management board
ARTES Biotechnology GmbH announced today that Volker Jenzelewski reinforces the executive board of ARTES as Managing Dir…
ARTES Biotechnology GmbH announced today that Volker Jenzelewski reinforces the executive board of ARTES as Managing Dir…
company focusing on niche pharmaceutical products, are proud to announce a strategic collaboration aimed at advancing ph…
In 2002 at May 10th Michael Piontek founded ARTES as a one-man operation executing and taking care of two license deals…
Today, Cellumed Co. Ltd., listed stock market company and Germany based ARTES Biotechnology GmbH announce the execution…
ARTES Biotechnology, the German-based biotech company specializing in process development for recombinant vaccines, ente…
ARTES Biotechnology and Burnet Institute recently published data on the efficient production of malaria vaccine candidat…
ARTES Biotechnology announces the acquisition of the unique SplitCore technology developed by scientists at the Universi…
ARTES Biotechnology GmbH, Germany, and Minapharm Pharmaceuticals and Chemical Industries S.A.E., Egypt, jointly announce…
Under the titel: “ERA-Net EuroTransBio-8: PLURIVAX, development of a virus-like-particle (VLP) based vaccine platform an…
The French R&D tax credit CIR gives French companies the ability to claim tax relief on 30% on all generated costs outso…